| 1. Jorgensen WL, Duffy EM.. (2000) Prediction of drug solubility from Monte Carlo simulations., 10 (11): [PMID:10866370] [10.1016/s0960-894x(00)00172-4] |
| 2. Liu G, Huth JR, Olejniczak ET, Mendoza R, DeVries P, Leitza S, Reilly EB, Okasinski GF, Fesik SW, von Geldern TW.. (2001) Novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intracellular adhesion molecule-1 interaction. 2. Mechanism of inhibition and structure-based improvement of pharmaceutical properties., 44 (8): [PMID:11312920] [10.1021/jm000503f] |
| 3. Sasaki S, Mizushima T, Hashimoto T, Maeda M, Kazuhisa S. (1994) 3-Acetoxy-2,2-bi-1H-indol as a novel inhibitor of ATP binding to DnaA, the protein initiating chromosomal replication in escherichia coli, 4 (14): [10.1016/S0960-894X(00)80378-9] |
| 4. Minick DJ, Frenz JH, Patrick MA, Brent DA.. (1988) A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography., 31 (10): [PMID:3172126] [10.1021/jm00118a010] |
| 5. Matassa VG, Brown FJ, Bernstein PR, Shapiro HS, Maduskuie TP, Cronk LA, Vacek EP, Yee YK, Snyder DW, Krell RD.. (1990) Synthesis and in vitro LTD4 antagonist activity of bicyclic and monocyclic cyclopentylurethane and cyclopentylacetamide N-arylsulfonyl amides., 33 (9): [PMID:2167983] [10.1021/jm00171a043] |
| 6. Guengerich FP, Sorrells JL, Schmitt S, Krauser JA, Aryal P, Meijer L.. (2004) Generation of new protein kinase inhibitors utilizing cytochrome p450 mutant enzymes for indigoid synthesis., 47 (12): [PMID:15163202] [10.1021/jm030561b] |
| 7. Erlanson DA, McDowell RS, O'Brien T.. (2004) Fragment-based drug discovery., 47 (14): [PMID:15214773] [10.1021/jm040031v] |
| 8. Hajduk PJ, Gomtsyan A, Didomenico S, Cowart M, Bayburt EK, Solomon L, Severin J, Smith R, Walter K, Holzman TF, Stewart A, McGaraughty S, Jarvis MF, Kowaluk EA, Fesik SW.. (2000) Design of adenosine kinase inhibitors from the NMR-based screening of fragments., 43 (25): [PMID:11123986] [10.1021/jm000373a] |
| 9. Caron G, Ermondi G.. (2005) Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk)., 48 (9): [PMID:15857133] [10.1021/jm048980b] |
| 10. Graves AP, Brenk R, Shoichet BK.. (2005) Decoys for docking., 48 (11): [PMID:15916423] [10.1021/jm0491187] |
| 11. Székelyhidi Z, Pató J, Wáczek F, Bánhegyi P, Hegymegi-Barakonyi B, Erös D, Mészáros G, Hollósy F, Hafenbradl D, Obert S, Klebl B, Kéri G, Orfi L.. (2005) Synthesis of selective SRPK-1 inhibitors: novel tricyclic quinoxaline derivatives., 15 (13): [PMID:15925511] [10.1016/j.bmcl.2005.04.064] |
| 12. Hyatt JL, Moak T, Hatfield MJ, Tsurkan L, Edwards CC, Wierdl M, Danks MK, Wadkins RM, Potter PM.. (2007) Selective inhibition of carboxylesterases by isatins, indole-2,3-diones., 50 (8): [PMID:17378546] [10.1021/jm061471k] |
| 13. Fujikawa M, Nakao K, Shimizu R, Akamatsu M.. (2007) QSAR study on permeability of hydrophobic compounds with artificial membranes., 15 (11): [PMID:17418579] [10.1016/j.bmc.2007.03.040] |
| 14. Kubo I, Muroi H, Kubo A.. (1994) Naturally occurring antiacne agents., 57 (1): [PMID:8158169] [10.1021/np50103a002] |
| 15. Toulmin A, Wood JM, Kenny PW.. (2008) Toward prediction of alkane/water partition coefficients., 51 (13): [PMID:18558667] [10.1021/jm701549s] |
| 16. Reinke AA, Seh HY, Gestwicki JE.. (2009) A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta., 19 (17): [PMID:19640715] [10.1016/j.bmcl.2009.07.082] |
| 17. Nyanguile O, Pauwels F, Van den Broeck W, Boutton CW, Quirynen L, Ivens T, van der Helm L, Vandercruyssen G, Mostmans W, Delouvroy F, Dehertogh P, Cummings MD, Bonfanti JF, Simmen KA, Raboisson P.. (2008) 1,5-benzodiazepines, a novel class of hepatitis C virus polymerase nonnucleoside inhibitors., 52 (12): [PMID:18852280] [10.1128/aac.00669-08] |
| 18. Ekinci D, Cavdar H, Durdagi S, Talaz O, Sentürk M, Supuran CT.. (2012) Structure-activity relationships for the interaction of 5,10-dihydroindeno[1,2-b]indole derivatives with human and bovine carbonic anhydrase isoforms I, II, III, IV and VI., 49 [PMID:22245047] [10.1016/j.ejmech.2011.12.022] |
| 19. Subba Reddy BV, Rajeswari N, Sarangapani M, Prashanthi Y, Ganji RJ, Addlagatta A.. (2012) Iodine-catalyzed condensation of isatin with indoles: a facile synthesis of di(indolyl)indolin-2-ones and evaluation of their cytotoxicity., 22 (7): [PMID:22386528] [10.1016/j.bmcl.2012.02.011] |
| 20. Seo S, Lee S, Hong Y, Kim Y.. (2012) Phospholipase A2 inhibitors synthesized by two entomopathogenic bacteria, Xenorhabdus nematophila and Photorhabdus temperata subsp. temperata., 78 (11): [PMID:22447611] [10.1128/aem.00301-12] |
| 21. Buemi MR, De Luca L, Chimirri A, Ferro S, Gitto R, Alvarez-Builla J, Alajarin R.. (2013) Indole derivatives as dual-effective agents for the treatment of neurodegenerative diseases: synthesis, biological evaluation, and molecular modeling studies., 21 (15): [PMID:23777828] [10.1016/j.bmc.2013.05.044] |
| 22. Gitto R, De Luca L, Ferro S, Russo E, De Sarro G, Chisari M, Ciranna L, Alvarez-Builla J, Alajarin R, Buemi MR, Chimirri A.. (2014) Synthesis, modelling and biological characterization of 3-substituted-1H-indoles as ligands of GluN2B-containing N-methyl-d-aspartate receptors., 22 (3): [PMID:24411196] [10.1016/j.bmc.2013.12.040] |
| 23. PubChem BioAssay data set, |
| 24. PubChem BioAssay data set, |
| 25. PubChem BioAssay data set, |
| 26. PubChem BioAssay data set, |
| 27. Bell MR, Zalay AW, Oesterlin R, Clemans SD, Dumas DJ, Bradford JC, Rozitis J.. (1977) Experimental antiulcer drugs. 1. Indole-1-alkanamides and pyrrole-1-alkanamides., 20 (4): [PMID:850239] [10.1021/jm00214a015] |
| 28. Cala O, Krimm I.. (2015) Ligand-Orientation Based Fragment Selection in STD NMR Screening., 58 (21): [PMID:26492576] [10.1021/acs.jmedchem.5b01114] |
| 29. Fortes MP, da Silva PB, da Silva TG, Kaufman TS, Militão GC, Silveira CC.. (2016) Synthesis and preliminary evaluation of 3-thiocyanato-1H-indoles as potential anticancer agents., 118 [PMID:27116711] [10.1016/j.ejmech.2016.04.039] |
| 30. Sherer C, Tolaymat I, Rowther F, Warr T, Snape TJ.. (2017) Preliminary SAR on indole-3-carbinol and related fragments reveals a novel anticancer lead compound against resistant glioblastoma cells., 27 (7): [PMID:28256372] [10.1016/j.bmcl.2017.02.033] |
| 31. Chavarria D, Fernandes C, Silva V, Silva C, Gil-Martins E, Soares P, Silva T, Silva R, Remião F, Oliveira PJ, Borges F.. (2020) Design of novel monoamine oxidase-B inhibitors based on piperine scaffold: Structure-activity-toxicity, drug-likeness and efflux transport studies., 185 [PMID:31711793] [10.1016/j.ejmech.2019.111770] |
| 32. Sherer C, Prabhu S, Adams D, Hayes J, Rowther F, Tolaymat I, Warr T, Snape TJ.. (2018) Towards identifying potent new hits for glioblastoma., 9 (11): [PMID:30568753] [10.1039/C8MD00436F] |
| 33. Iwata H,Kanda N,Araki M,Sagae Y,Masuda K,Okuno Y. (2021) Discovery of natural TRPA1 activators through pharmacophore-based virtual screening and a biological assay., 31 [PMID:33129991] [10.1016/j.bmcl.2020.127639] |
| 34. Lee D, Kim KH, Jang TS, Kang KS.. (2021) Identification of bioactive compounds from mulberry enhancing glucose-stimulated insulin secretion., 43 [PMID:33984475] [10.1016/j.bmcl.2021.128096] |
| 35. Urvashi, Senthil Kumar JB, Das P, Tandon V.. (2022) Development of Azaindole-Based Frameworks as Potential Antiviral Agents and Their Future Perspectives., 65 (9.0): [PMID:35477274] [10.1021/acs.jmedchem.2c00444] |
| 36. Lin L, Dai Y, Xia Y.. (2022) An overview of aryl hydrocarbon receptor ligands in the Last two decades (2002-2022): A medicinal chemistry perspective., 244 [PMID:36274276] [10.1016/j.ejmech.2022.114845] |
